{
    "nctId": "NCT03137095",
    "briefTitle": "Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI",
    "officialTitle": "Longitudinal Pilot Mechanistic Study of the Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients and Non-Cancer Control Participants - Optional Sub-Study: Research Brain MRI",
    "overallStatus": "RECRUITING",
    "conditions": "Cancer Related Cognitive Difficulties, Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Cognitive function (memory, concentration, attentiveness) will be assessed by computerized cognitive assessments and associated with inflammation and neurotoxicity markers",
    "eligibilityCriteria": "Inclusion Criteria, Breast Cancer Patient Participants:\n\n* Females with a diagnosis of invasive non-metastatic breast cancer (stage I-IIIC)\n* Scheduled to begin a course of chemotherapy with Adriamycin and Cytoxan\n* Chemotherapy na\u00efve\n* Able to speak and read English\n* 21 years or older\n* Give written informed consent\n\nExclusion Criteria, Breast Cancer Patient Participants:\n\n* Must not be currently hospitalized or have been hospitalized within the last year for a psychiatric illness\n* Must not be diagnosed with a neurodegenerative disease (e.g., Alzheimer's disease, Parkinson's disease)\n* Must not have any Central Nervous System disease (e.g., movement disorder, multiple sclerosis)\n* Subjects could have had a TIA (transient ischemic attack) or stroke in the past if the TIA or stroke was greater than 1 year ago and the subject does not have any remaining symptoms\n* Must not be scheduled to receive concurrent radiation treatment while receiving chemotherapy.\n* Must not be colorblind\n\nInclusion Criteria, Control Participants:\n\n* Must be female and within 5 years of the age of the subject receiving chemotherapy\n* Able to speak and read English\n* Give written informed consent\n* 21 years or older\n\nExclusion Criteria, Control Participants:\n\n* Must not be currently hospitalized or have been hospitalized within the last year for a psychiatric illness\n* Must not be diagnosed with a neurodegenerative disease (e.g. Alzheimer's disease, Parkinson's disease)\n* Must not have Central Nervous System disease (e.g., movement disorder, multiple sclerosis)\n* Subjects could have had a TIA (transient ischemic attack) or stroke in the past if the TIA or stroke was greater than 1 year ago and the subject does not have any remaining symptoms\n* Must not have been diagnosed with cancer or previously have received chemotherapy\n* Must not be colorblind\n\nFor optional sub-study: MR safety assessed via Rochester Center for Brain Imaging Magnetic Resonance (MR) Safety Screening Form to confirm eligibility to participate",
    "sex": "FEMALE",
    "minimumAge": "21 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}